143 related articles for article (PubMed ID: 32499070)
41. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months.
Armer JM; Stewart BR
Lymphology; 2010 Sep; 43(3):118-27. PubMed ID: 21226414
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
43. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
Armer JM; Ballman KV; McCall L; Armer NC; Sun Y; Udmuangpia T; Hunt KK; Mittendorf EA; Byrd DR; Julian TB; Boughey JC
Support Care Cancer; 2019 Feb; 27(2):495-503. PubMed ID: 29980907
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
45. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging.
Ghezzi F; Uccella S; Cromi A; Bogani G; Robba C; Serati M; Bolis P
Ann Surg Oncol; 2012 Jan; 19(1):259-67. PubMed ID: 21695563
[TBL] [Abstract][Full Text] [Related]
46. Evidence-based practice in the management of lower limb lymphedema after gynecological cancer.
Iwersen LF; Sperandio FF; Toriy AM; Palú M; Medeiros da Luz C
Physiother Theory Pract; 2017 Jan; 33(1):1-8. PubMed ID: 27918865
[TBL] [Abstract][Full Text] [Related]
47. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
48. A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer.
Hopp EE; Osborne JL; Schneider DK; Bojar CJ; Uyar DS
Gynecol Oncol Rep; 2016 Jan; 15():25-8. PubMed ID: 26937484
[TBL] [Abstract][Full Text] [Related]
49. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
50. Lumbar Sympathetic Ganglion Block for Cancer-Associated Secondary Lower Limb Lymphedema: A Retrospective Study.
Huang H; Lin J; Dai Z; Zeng M; Li S; Zheng H
Pain Physician; 2022 Nov; 25(8):E1269-E1277. PubMed ID: 36375200
[TBL] [Abstract][Full Text] [Related]
51. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.
Hayes S; Janda M; Cornish B; Battistutta D; Newman B
Lymphology; 2008 Mar; 41(1):18-28. PubMed ID: 18581955
[TBL] [Abstract][Full Text] [Related]
52. Factors Influencing Lower Limb Lymphedema After Cervical Cancer Surgery: A Case-Control Study.
Liu G; Hu J; Liu Y; Yuan M
Lymphat Res Biol; 2023 Apr; 21(2):169-178. PubMed ID: 35905037
[No Abstract] [Full Text] [Related]
53. Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.
Cibula D; Borčinová M; Marnitz S; Jarkovský J; Klát J; Pilka R; Torné A; Zapardiel I; Petiz A; Lay L; Sehnal B; Ponce J; Felsinger M; Arencibia-Sánchez O; Kaščák P; Zalewski K; Presl J; Palop-Moscardó A; Tingulstad S; Vergote I; Redecha M; Frühauf F; Köhler C; Kocián R
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068399
[TBL] [Abstract][Full Text] [Related]
54. The frequency and persistence of lymphedema diagnosis and self-reported symptoms over 5 years in patients with endometrial carcinoma.
Ritchie J; Heyward Q; Taylor N; Ko E; Haggerty AF; Graul A
Gynecol Oncol Rep; 2022 Jun; 41():100996. PubMed ID: 35592241
[TBL] [Abstract][Full Text] [Related]
55. Association of Lower Extremity Lymphedema With Physical Functioning and Activities of Daily Living Among Older Survivors of Colorectal, Endometrial, and Ovarian Cancer.
Zhang X; McLaughlin EM; Krok-Schoen JL; Naughton M; Bernardo BM; Cheville A; Allison M; Stefanick M; Bea JW; Paskett ED
JAMA Netw Open; 2022 Mar; 5(3):e221671. PubMed ID: 35262713
[TBL] [Abstract][Full Text] [Related]
56. The prevalence of lymphedema symptoms among survivors of long-term cancer with or at risk for lower limb lymphedema.
Brown JC; Chu CS; Cheville AL; Schmitz KH
Am J Phys Med Rehabil; 2013 Mar; 92(3):223-31. PubMed ID: 23069748
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and prognostic significance of secondary lymphedema following breast cancer.
Hayes S; Di Sipio T; Rye S; López JA; Saunders C; Pyke C; Bashford J; Battistutta D; Newman B
Lymphat Res Biol; 2011; 9(3):135-41. PubMed ID: 22066743
[TBL] [Abstract][Full Text] [Related]
58. Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
McDuff SGR; Mina AI; Brunelle CL; Salama L; Warren LEG; Abouegylah M; Swaroop M; Skolny MN; Asdourian M; Gillespie T; Daniell K; Sayegh HE; Naoum GE; Zheng H; Taghian AG
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):62-70. PubMed ID: 30165125
[TBL] [Abstract][Full Text] [Related]
59. The role of information sources and objective risk status on lymphedema risk-minimization behaviors in women recently diagnosed with breast cancer.
Sherman KA; Koelmeyer L
Oncol Nurs Forum; 2011 Jan; 38(1):E27-36. PubMed ID: 21186149
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer related lymphedema in patients with different loco-regional treatments.
Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
